This could be due to differences in the IC50 values of each inhibitor [30–32], and/or because the degree of PARP trapping likely influences the sensitivity of NB cell lines to PARP inhibitors regardless of MYCN expression. This evidence concerns the gene MYCN and neuroblastoma.